

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.83051684 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 4.68431312 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.68431312 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.68431312 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.68431312 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.68431312 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.68431312 |
| 8 | hypotonic response (GO:0006971) | 3.93363884 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.79001823 |
| 10 | response to peptidoglycan (GO:0032494) | 3.60640359 |
| 11 | definitive hemopoiesis (GO:0060216) | 3.55168624 |
| 12 | wound healing, spreading of epidermal cells (GO:0035313) | 3.52684371 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 3.41698059 |
| 14 | regulation of platelet activation (GO:0010543) | 3.36794585 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.26601396 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 3.23317067 |
| 17 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21397157 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.20365597 |
| 19 | positive regulation of receptor recycling (GO:0001921) | 3.12370408 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07992154 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.07146831 |
| 22 | response to host immune response (GO:0052572) | 3.07146831 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.04859757 |
| 24 | positive regulation of hemostasis (GO:1900048) | 3.04737186 |
| 25 | positive regulation of blood coagulation (GO:0030194) | 3.04737186 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.04321470 |
| 27 | endothelium development (GO:0003158) | 3.03369018 |
| 28 | regulation of early endosome to late endosome transport (GO:2000641) | 3.02914435 |
| 29 | stress fiber assembly (GO:0043149) | 3.02752778 |
| 30 | response to muramyl dipeptide (GO:0032495) | 3.01570760 |
| 31 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.01502137 |
| 32 | morphogenesis of an endothelium (GO:0003159) | 2.97657331 |
| 33 | endothelial tube morphogenesis (GO:0061154) | 2.97657331 |
| 34 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.97419611 |
| 35 | angiogenesis involved in wound healing (GO:0060055) | 2.96861900 |
| 36 | thrombin receptor signaling pathway (GO:0070493) | 2.96858450 |
| 37 | positive regulation of coagulation (GO:0050820) | 2.96335871 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96147991 |
| 39 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.95875015 |
| 40 | regulation of integrin activation (GO:0033623) | 2.95630116 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93322154 |
| 42 | response to host (GO:0075136) | 2.93322154 |
| 43 | response to host defenses (GO:0052200) | 2.93322154 |
| 44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.92885607 |
| 45 | response to interferon-alpha (GO:0035455) | 2.91530131 |
| 46 | positive regulation of mast cell activation (GO:0033005) | 2.90763013 |
| 47 | regulation of meiosis I (GO:0060631) | 2.89860418 |
| 48 | substrate-dependent cell migration (GO:0006929) | 2.89335619 |
| 49 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87339795 |
| 50 | apoptotic cell clearance (GO:0043277) | 2.87002620 |
| 51 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82396250 |
| 52 | germ cell migration (GO:0008354) | 2.82056622 |
| 53 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.81984797 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81145058 |
| 55 | regulation of platelet aggregation (GO:0090330) | 2.80663416 |
| 56 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77956567 |
| 57 | granulocyte activation (GO:0036230) | 2.75599874 |
| 58 | phagocytosis, engulfment (GO:0006911) | 2.75349977 |
| 59 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.73173400 |
| 60 | positive regulation of focal adhesion assembly (GO:0051894) | 2.73047982 |
| 61 | positive regulation of cell junction assembly (GO:1901890) | 2.73047982 |
| 62 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.68886776 |
| 63 | positive regulation of adherens junction organization (GO:1903393) | 2.68336557 |
| 64 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.67551454 |
| 65 | basement membrane organization (GO:0071711) | 2.66910224 |
| 66 | negative regulation of platelet activation (GO:0010544) | 2.66602912 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 2.65132456 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 2.64234978 |
| 69 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.64114350 |
| 70 | mitotic sister chromatid cohesion (GO:0007064) | 2.63751114 |
| 71 | endodermal cell differentiation (GO:0035987) | 2.63320349 |
| 72 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.63316377 |
| 73 | skin morphogenesis (GO:0043589) | 2.63315900 |
| 74 | protein localization to endosome (GO:0036010) | 2.62989715 |
| 75 | neutrophil activation (GO:0042119) | 2.60813714 |
| 76 | I-kappaB phosphorylation (GO:0007252) | 2.59544823 |
| 77 | blood vessel maturation (GO:0001955) | 2.59213482 |
| 78 | cellular extravasation (GO:0045123) | 2.58472803 |
| 79 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57809024 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 2.57784978 |
| 81 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.57414467 |
| 82 | natural killer cell mediated immunity (GO:0002228) | 2.57414467 |
| 83 | cellular response to virus (GO:0098586) | 2.56671823 |
| 84 | negative regulation of focal adhesion assembly (GO:0051895) | 2.56477145 |
| 85 | negative regulation of cell junction assembly (GO:1901889) | 2.56477145 |
| 86 | negative regulation of adherens junction organization (GO:1903392) | 2.56477145 |
| 87 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.54981992 |
| 88 | adenosine receptor signaling pathway (GO:0001973) | 2.54567460 |
| 89 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.54180257 |
| 90 | regulation of podosome assembly (GO:0071801) | 2.52262218 |
| 91 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.51247793 |
| 92 | detection of molecule of bacterial origin (GO:0032490) | 2.50506276 |
| 93 | cellular response to interferon-alpha (GO:0035457) | 2.50063200 |
| 94 | nerve growth factor signaling pathway (GO:0038180) | 2.47126949 |
| 95 | low-density lipoprotein particle clearance (GO:0034383) | 2.47061640 |
| 96 | mRNA transcription (GO:0009299) | 2.46709270 |
| 97 | respiratory burst (GO:0045730) | 2.46371305 |
| 98 | regulation of cholesterol storage (GO:0010885) | 2.46151656 |
| 99 | mesodermal cell differentiation (GO:0048333) | 2.45234082 |
| 100 | SMAD protein complex assembly (GO:0007183) | 2.44801519 |
| 101 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44291564 |
| 102 | membrane invagination (GO:0010324) | 2.43323204 |
| 103 | Rap protein signal transduction (GO:0032486) | 2.42859971 |
| 104 | positive regulation of vasculogenesis (GO:2001214) | 2.42768526 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 2.41320194 |
| 106 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.40607843 |
| 107 | megakaryocyte development (GO:0035855) | 2.39975657 |
| 108 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.37754355 |
| 109 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.37113733 |
| 110 | positive regulation of leukocyte degranulation (GO:0043302) | 2.36907797 |
| 111 | negative regulation of stress fiber assembly (GO:0051497) | 2.36512990 |
| 112 | establishment of endothelial barrier (GO:0061028) | 2.36139386 |
| 113 | B cell mediated immunity (GO:0019724) | 2.35982094 |
| 114 | regulation of cell junction assembly (GO:1901888) | 2.35946485 |
| 115 | negative regulation of lipid storage (GO:0010888) | 2.35465992 |
| 116 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.33961429 |
| 117 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.33878267 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.33842478 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.33678851 |
| 120 | leukocyte cell-cell adhesion (GO:0007159) | 2.33329509 |
| 121 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.32989178 |
| 122 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.32396375 |
| 123 | positive regulation of p38MAPK cascade (GO:1900745) | 2.32217267 |
| 124 | superoxide anion generation (GO:0042554) | 2.30345682 |
| 125 | actin nucleation (GO:0045010) | 2.29528237 |
| 126 | regulation of mast cell activation (GO:0033003) | 2.28452582 |
| 127 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.28389349 |
| 128 | peptide catabolic process (GO:0043171) | 2.28222077 |
| 129 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.27473970 |
| 130 | regulation of focal adhesion assembly (GO:0051893) | 2.27371803 |
| 131 | regulation of cell-substrate junction assembly (GO:0090109) | 2.27371803 |
| 132 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.27045691 |
| 133 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.26904710 |
| 134 | macrophage activation (GO:0042116) | 2.26299926 |
| 135 | regulation of adherens junction organization (GO:1903391) | 2.26186914 |
| 136 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.25395306 |
| 137 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.25395306 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25316823 |
| 139 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.24963396 |
| 140 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.24865457 |
| 141 | positive regulation of interleukin-6 production (GO:0032755) | 2.24167629 |
| 142 | pinocytosis (GO:0006907) | 2.24162623 |
| 143 | response to vitamin D (GO:0033280) | 2.23659112 |
| 144 | regulation of leukocyte degranulation (GO:0043300) | 2.23488881 |
| 145 | regulation of macrophage cytokine production (GO:0010935) | 2.23155245 |
| 146 | response to laminar fluid shear stress (GO:0034616) | 2.22786445 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.22505927 |
| 148 | positive regulation of mast cell degranulation (GO:0043306) | 2.22505927 |
| 149 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.21954493 |
| 150 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.21744701 |
| 151 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.21576771 |
| 152 | lymphangiogenesis (GO:0001946) | 2.21023262 |
| 153 | wound healing, spreading of cells (GO:0044319) | 2.21022017 |
| 154 | integrin-mediated signaling pathway (GO:0007229) | 2.20968315 |
| 155 | lymph vessel development (GO:0001945) | 2.20786865 |
| 156 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.20109906 |
| 157 | hippo signaling (GO:0035329) | 2.19304743 |
| 158 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.19251555 |
| 159 | leukocyte aggregation (GO:0070486) | 2.19171475 |
| 160 | myeloid cell homeostasis (GO:0002262) | 2.18495355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.53888765 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.29245325 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.14029362 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.40553586 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31941980 |
| 6 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.16001518 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.00595511 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.94212094 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.90314674 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83666042 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.82649543 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.78195005 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.76273769 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67057105 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67004269 |
| 16 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.52586865 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.40851326 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.37595375 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34364662 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33367312 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.32146150 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.22066431 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.22066431 |
| 24 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.22066431 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21746427 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.15846569 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09648557 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05642255 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01781028 |
| 30 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.97395663 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.95853255 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87149955 |
| 33 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82941997 |
| 34 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.82884723 |
| 35 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81253897 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76558424 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74967478 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74724525 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.72590160 |
| 40 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.72590160 |
| 41 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.71871618 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69283747 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.64636084 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.64213277 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.62760462 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62184641 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60789805 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58709177 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56488900 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55895475 |
| 51 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.55716943 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55106056 |
| 53 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53904862 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.52849098 |
| 55 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51242488 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50768244 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.48942712 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.47163280 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47049842 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44330359 |
| 61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43991494 |
| 62 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.42971190 |
| 63 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38558724 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36697738 |
| 65 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35990791 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35712687 |
| 67 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35336721 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.35312806 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34745363 |
| 70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34477457 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33864874 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.33814453 |
| 73 | MYB_26560356_Chip-Seq_TH2_Human | 1.33011073 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31838393 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30509754 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27931532 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.27658847 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26582628 |
| 79 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.26053763 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26019743 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25355251 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24885625 |
| 83 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24792540 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 1.24132830 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23034527 |
| 86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22121495 |
| 87 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20770881 |
| 88 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.20682979 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.17690884 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17565521 |
| 91 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17080244 |
| 92 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15191404 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.14786309 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13682251 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.13092195 |
| 96 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.12634131 |
| 97 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11918858 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11715123 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.11010698 |
| 100 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10385874 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10322356 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10258235 |
| 103 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10120706 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09829336 |
| 105 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09818522 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09497217 |
| 107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.08706282 |
| 108 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.08227986 |
| 109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06870788 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06708952 |
| 111 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06397032 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06338379 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06167995 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05955443 |
| 115 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.05548919 |
| 116 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.03764578 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03033788 |
| 118 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01771242 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00918394 |
| 120 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00910521 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00724965 |
| 122 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99063412 |
| 123 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99001768 |
| 124 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98293575 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96661826 |
| 126 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94887038 |
| 127 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94681317 |
| 128 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94681317 |
| 129 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.94659471 |
| 130 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94603705 |
| 131 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94136402 |
| 132 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94010917 |
| 133 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91711242 |
| 134 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91258748 |
| 135 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.90540218 |
| 136 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90031056 |
| 137 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89549905 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89368652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.09654452 |
| 2 | MP0008004_abnormal_stomach_pH | 3.08054393 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.07485579 |
| 4 | MP0003436_decreased_susceptibility_to | 2.68695906 |
| 5 | MP0009278_abnormal_bone_marrow | 2.63952214 |
| 6 | MP0003724_increased_susceptibility_to | 2.63627185 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.51540920 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.29997732 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.25396990 |
| 10 | MP0005076_abnormal_cell_differentiation | 2.23941832 |
| 11 | MP0001879_abnormal_lymphatic_vessel | 2.18709159 |
| 12 | MP0005167_abnormal_blood-brain_barrier | 1.99623287 |
| 13 | MP0003828_pulmonary_edema | 1.98529505 |
| 14 | MP0002419_abnormal_innate_immunity | 1.97607366 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 1.97274426 |
| 16 | MP0004808_abnormal_hematopoietic_stem | 1.86722450 |
| 17 | MP0003448_altered_tumor_morphology | 1.85201598 |
| 18 | MP0009785_altered_susceptibility_to | 1.84020384 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 1.83875003 |
| 20 | MP0000343_altered_response_to | 1.82182035 |
| 21 | MP0004510_myositis | 1.81809033 |
| 22 | MP0001958_emphysema | 1.81686525 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.77966152 |
| 24 | MP0004272_abnormal_basement_membrane | 1.77118766 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.77087201 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.77087201 |
| 27 | MP0005409_darkened_coat_color | 1.76960216 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.74494138 |
| 29 | MP0003279_aneurysm | 1.66064102 |
| 30 | MP0002796_impaired_skin_barrier | 1.65711448 |
| 31 | MP0000733_abnormal_muscle_development | 1.63659884 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.61870322 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.61808671 |
| 34 | MP0005025_abnormal_response_to | 1.54638529 |
| 35 | MP0008260_abnormal_autophagy | 1.53480690 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.51467881 |
| 37 | * MP0005000_abnormal_immune_tolerance | 1.50520788 |
| 38 | MP0003091_abnormal_cell_migration | 1.48515636 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.47761984 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.47532431 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.46768837 |
| 42 | MP0004883_abnormal_blood_vessel | 1.45690013 |
| 43 | MP0006082_CNS_inflammation | 1.45495147 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.43315909 |
| 45 | MP0000767_abnormal_smooth_muscle | 1.42478129 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.37837066 |
| 47 | MP0006054_spinal_hemorrhage | 1.37715646 |
| 48 | MP0010307_abnormal_tumor_latency | 1.32151329 |
| 49 | MP0002405_respiratory_system_inflammati | 1.31684392 |
| 50 | MP0004947_skin_inflammation | 1.31416111 |
| 51 | MP0005023_abnormal_wound_healing | 1.30198737 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.29774285 |
| 53 | MP0004084_abnormal_cardiac_muscle | 1.28481496 |
| 54 | MP0003941_abnormal_skin_development | 1.26533229 |
| 55 | MP0001853_heart_inflammation | 1.24925790 |
| 56 | MP0002254_reproductive_system_inflammat | 1.23693988 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.22072995 |
| 58 | MP0000858_altered_metastatic_potential | 1.21717985 |
| 59 | MP0005275_abnormal_skin_tensile | 1.21346898 |
| 60 | * MP0001819_abnormal_immune_cell | 1.20917766 |
| 61 | * MP0002420_abnormal_adaptive_immunity | 1.20306855 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.18229111 |
| 63 | MP0010234_abnormal_vibrissa_follicle | 1.17573080 |
| 64 | * MP0002723_abnormal_immune_serum | 1.16541397 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.16236914 |
| 66 | MP0001800_abnormal_humoral_immune | 1.14518300 |
| 67 | MP0005390_skeleton_phenotype | 1.12247038 |
| 68 | MP0001915_intracranial_hemorrhage | 1.12148759 |
| 69 | MP0009764_decreased_sensitivity_to | 1.11674235 |
| 70 | MP0010155_abnormal_intestine_physiology | 1.11633390 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 1.09221426 |
| 72 | MP0005164_abnormal_response_to | 1.09115656 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 1.08934681 |
| 74 | MP0005666_abnormal_adipose_tissue | 1.07574193 |
| 75 | MP0001790_abnormal_immune_system | 1.06885172 |
| 76 | MP0005387_immune_system_phenotype | 1.06885172 |
| 77 | MP0002006_tumorigenesis | 1.06770913 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.06082078 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.05024239 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.04970354 |
| 81 | MP0005174_abnormal_tail_pigmentation | 1.04876622 |
| 82 | MP0003075_altered_response_to | 1.01410995 |
| 83 | MP0005166_decreased_susceptibility_to | 1.01163431 |
| 84 | MP0005671_abnormal_response_to | 1.01084888 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.00791801 |
| 86 | MP0001849_ear_inflammation | 1.00066747 |
| 87 | MP0001851_eye_inflammation | 0.99158548 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.98371609 |
| 89 | MP0009053_abnormal_anal_canal | 0.97491079 |
| 90 | * MP0002398_abnormal_bone_marrow | 0.96948556 |
| 91 | MP0002128_abnormal_blood_circulation | 0.96857808 |
| 92 | * MP0002925_abnormal_cardiovascular_devel | 0.96463887 |
| 93 | MP0005623_abnormal_meninges_morphology | 0.96144413 |
| 94 | * MP0001614_abnormal_blood_vessel | 0.95002529 |
| 95 | MP0009384_cardiac_valve_regurgitation | 0.94550223 |
| 96 | * MP0002086_abnormal_extraembryonic_tissu | 0.94495623 |
| 97 | MP0004185_abnormal_adipocyte_glucose | 0.92530651 |
| 98 | MP0006138_congestive_heart_failure | 0.91124774 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.90670134 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.89909068 |
| 101 | MP0002133_abnormal_respiratory_system | 0.89723049 |
| 102 | MP0005388_respiratory_system_phenotype | 0.89723049 |
| 103 | MP0004782_abnormal_surfactant_physiolog | 0.89332739 |
| 104 | MP0000249_abnormal_blood_vessel | 0.89197411 |
| 105 | MP0010678_abnormal_skin_adnexa | 0.89041970 |
| 106 | MP0008469_abnormal_protein_level | 0.87683344 |
| 107 | MP0005367_renal/urinary_system_phenotyp | 0.86095626 |
| 108 | MP0000516_abnormal_urinary_system | 0.86095626 |
| 109 | * MP0000716_abnormal_immune_system | 0.86079014 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.85921170 |
| 111 | MP0002060_abnormal_skin_morphology | 0.84455439 |
| 112 | MP0000490_abnormal_crypts_of | 0.84196395 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83127562 |
| 114 | MP0001730_embryonic_growth_arrest | 0.82903511 |
| 115 | MP0005501_abnormal_skin_physiology | 0.82690450 |
| 116 | MP0005621_abnormal_cell_physiology | 0.82668580 |
| 117 | MP0001542_abnormal_bone_strength | 0.81831969 |
| 118 | MP0005451_abnormal_body_composition | 0.80807742 |
| 119 | MP0000383_abnormal_hair_follicle | 0.80093329 |
| 120 | * MP0002429_abnormal_blood_cell | 0.79496953 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.76805820 |
| 122 | MP0002722_abnormal_immune_system | 0.76651436 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.76368648 |
| 124 | MP0000685_abnormal_immune_system | 0.76087955 |
| 125 | MP0009840_abnormal_foam_cell | 0.75472040 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.75319534 |
| 127 | MP0004197_abnormal_fetal_growth/weight/ | 0.75263276 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.73177492 |
| 129 | MP0002896_abnormal_bone_mineralization | 0.71957848 |
| 130 | MP0010630_abnormal_cardiac_muscle | 0.71472799 |
| 131 | MP0001175_abnormal_lung_morphology | 0.71241708 |
| 132 | MP0001784_abnormal_fluid_regulation | 0.68657223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.46953219 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.18414227 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.91423984 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.85492244 |
| 5 | Hematochezia (HP:0002573) | 3.76011276 |
| 6 | Interstitial pulmonary disease (HP:0006530) | 3.20286414 |
| 7 | Papillary thyroid carcinoma (HP:0002895) | 3.08236118 |
| 8 | Ankle contracture (HP:0006466) | 2.96703137 |
| 9 | Prolonged bleeding time (HP:0003010) | 2.86000992 |
| 10 | Protrusio acetabuli (HP:0003179) | 2.84039173 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 2.83962186 |
| 12 | Spinal cord lesions (HP:0100561) | 2.82210924 |
| 13 | Syringomyelia (HP:0003396) | 2.82210924 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.77992296 |
| 15 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.77395901 |
| 16 | Osteolytic defects of the hand bones (HP:0009699) | 2.77395901 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.71795816 |
| 18 | Subacute progressive viral hepatitis (HP:0006572) | 2.71438171 |
| 19 | Disinhibition (HP:0000734) | 2.69072874 |
| 20 | Vascular tortuosity (HP:0004948) | 2.66681665 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 2.64395029 |
| 22 | Thick nail (HP:0001805) | 2.63452223 |
| 23 | Orchitis (HP:0100796) | 2.62695909 |
| 24 | Petechiae (HP:0000967) | 2.60950236 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60895741 |
| 26 | Arterial tortuosity (HP:0005116) | 2.58951990 |
| 27 | Myositis (HP:0100614) | 2.58491138 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.52538318 |
| 29 | Increased mean platelet volume (HP:0011877) | 2.52179455 |
| 30 | Esophageal varix (HP:0002040) | 2.51948032 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50668039 |
| 32 | Cervical subluxation (HP:0003308) | 2.49966674 |
| 33 | Myocardial infarction (HP:0001658) | 2.48861853 |
| 34 | Abnormal platelet volume (HP:0011876) | 2.45277581 |
| 35 | Cellulitis (HP:0100658) | 2.42061448 |
| 36 | Ankyloglossia (HP:0010296) | 2.39616887 |
| 37 | Curly hair (HP:0002212) | 2.39052814 |
| 38 | Shallow orbits (HP:0000586) | 2.37470401 |
| 39 | Menorrhagia (HP:0000132) | 2.37355822 |
| 40 | Gingivitis (HP:0000230) | 2.33175063 |
| 41 | Cerebral aneurysm (HP:0004944) | 2.31719644 |
| 42 | Peritonitis (HP:0002586) | 2.29767618 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.29430064 |
| 44 | Gingival bleeding (HP:0000225) | 2.28444491 |
| 45 | Absent frontal sinuses (HP:0002688) | 2.27745540 |
| 46 | Obstructive lung disease (HP:0006536) | 2.25659007 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25659007 |
| 48 | Vertebral arch anomaly (HP:0008438) | 2.25191812 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.23872336 |
| 50 | Recurrent skin infections (HP:0001581) | 2.23653689 |
| 51 | Recurrent fungal infections (HP:0002841) | 2.23069837 |
| 52 | Tetraparesis (HP:0002273) | 2.22882206 |
| 53 | Dilatation of the ascending aorta (HP:0005111) | 2.21766493 |
| 54 | Abnormal platelet function (HP:0011869) | 2.21058725 |
| 55 | Impaired platelet aggregation (HP:0003540) | 2.21058725 |
| 56 | Periodontitis (HP:0000704) | 2.19200885 |
| 57 | Abnormality of the nasal septum (HP:0000419) | 2.16295069 |
| 58 | Metaphyseal cupping (HP:0003021) | 2.14050465 |
| 59 | Mitral valve prolapse (HP:0001634) | 2.13305634 |
| 60 | Epistaxis (HP:0000421) | 2.12544844 |
| 61 | Arterial thrombosis (HP:0004420) | 2.10584971 |
| 62 | Aortic aneurysm (HP:0004942) | 2.10459549 |
| 63 | Vertebral compression fractures (HP:0002953) | 2.09685361 |
| 64 | Radial bowing (HP:0002986) | 2.09165396 |
| 65 | Prostate neoplasm (HP:0100787) | 2.07892582 |
| 66 | Increased connective tissue (HP:0009025) | 2.05126237 |
| 67 | Asymmetry of the thorax (HP:0001555) | 2.04385397 |
| 68 | Purpura (HP:0000979) | 2.01673912 |
| 69 | * Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.01050364 |
| 70 | Insidious onset (HP:0003587) | 1.97024123 |
| 71 | Termporal pattern (HP:0011008) | 1.97024123 |
| 72 | Polycythemia (HP:0001901) | 1.96624119 |
| 73 | Axonal loss (HP:0003447) | 1.96023605 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 1.95846260 |
| 75 | Leukocytosis (HP:0001974) | 1.95564036 |
| 76 | Optic neuritis (HP:0100653) | 1.94471279 |
| 77 | Retrobulbar optic neuritis (HP:0100654) | 1.94471279 |
| 78 | Thin bony cortex (HP:0002753) | 1.93025437 |
| 79 | Conjunctival telangiectasia (HP:0000524) | 1.92977439 |
| 80 | Short 4th metacarpal (HP:0010044) | 1.89569983 |
| 81 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.89569983 |
| 82 | * Transitional cell carcinoma of the bladder (HP:0006740) | 1.88919511 |
| 83 | Acute myeloid leukemia (HP:0004808) | 1.88423271 |
| 84 | Abnormality of oral frenula (HP:0000190) | 1.87167155 |
| 85 | Viral hepatitis (HP:0006562) | 1.86346032 |
| 86 | Rectal prolapse (HP:0002035) | 1.86233859 |
| 87 | Increased density of long bones (HP:0006392) | 1.86232365 |
| 88 | Amaurosis fugax (HP:0100576) | 1.85686120 |
| 89 | Biliary tract neoplasm (HP:0100574) | 1.85299829 |
| 90 | Broad face (HP:0000283) | 1.84657761 |
| 91 | Aortic dissection (HP:0002647) | 1.83639447 |
| 92 | * Bladder neoplasm (HP:0009725) | 1.83528815 |
| 93 | * Bladder carcinoma (HP:0002862) | 1.83528815 |
| 94 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82687002 |
| 95 | Bruising susceptibility (HP:0000978) | 1.81967917 |
| 96 | Micronodular cirrhosis (HP:0001413) | 1.81057696 |
| 97 | Nephritis (HP:0000123) | 1.80551598 |
| 98 | Abnormality of the pericardium (HP:0001697) | 1.79522607 |
| 99 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79502099 |
| 100 | Deep philtrum (HP:0002002) | 1.78847189 |
| 101 | * Malignant gastrointestinal tract tumors (HP:0006749) | 1.77954047 |
| 102 | * Gastrointestinal carcinoma (HP:0002672) | 1.77954047 |
| 103 | Hemorrhage of the eye (HP:0011885) | 1.77302823 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 1.76569476 |
| 105 | Pustule (HP:0200039) | 1.76491816 |
| 106 | Coarse hair (HP:0002208) | 1.76070502 |
| 107 | Spondylolisthesis (HP:0003302) | 1.75860822 |
| 108 | Thyroid carcinoma (HP:0002890) | 1.74877691 |
| 109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74119079 |
| 110 | Agnosia (HP:0010524) | 1.73987808 |
| 111 | Right ventricular cardiomyopathy (HP:0011663) | 1.73772083 |
| 112 | Urticaria (HP:0001025) | 1.73409453 |
| 113 | Recurrent viral infections (HP:0004429) | 1.72691484 |
| 114 | Wrist flexion contracture (HP:0001239) | 1.70992678 |
| 115 | Atrophic scars (HP:0001075) | 1.70686405 |
| 116 | * Leiomyosarcoma (HP:0100243) | 1.70513153 |
| 117 | * Uterine leiomyosarcoma (HP:0002891) | 1.70513153 |
| 118 | Biconcave vertebral bodies (HP:0004586) | 1.70200479 |
| 119 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.69334753 |
| 120 | Fused cervical vertebrae (HP:0002949) | 1.68364010 |
| 121 | Volvulus (HP:0002580) | 1.67585385 |
| 122 | Amyloidosis (HP:0011034) | 1.66878742 |
| 123 | Flat acetabular roof (HP:0003180) | 1.66527520 |
| 124 | Neurofibrillary tangles (HP:0002185) | 1.66018672 |
| 125 | Abnormality of glycolipid metabolism (HP:0010969) | 1.65261241 |
| 126 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.65261241 |
| 127 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.65261241 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.64915352 |
| 129 | Vasculitis (HP:0002633) | 1.63882987 |
| 130 | Portal hypertension (HP:0001409) | 1.62159738 |
| 131 | Mitral stenosis (HP:0001718) | 1.62026234 |
| 132 | Genu recurvatum (HP:0002816) | 1.60387472 |
| 133 | Bone pain (HP:0002653) | 1.58021660 |
| 134 | Porencephaly (HP:0002132) | 1.57811365 |
| 135 | Spinal rigidity (HP:0003306) | 1.57710501 |
| 136 | Abnormal vertebral ossification (HP:0100569) | 1.56921165 |
| 137 | Pulmonary infiltrates (HP:0002113) | 1.56554400 |
| 138 | Rickets (HP:0002748) | 1.55977462 |
| 139 | Abnormality of the fingertips (HP:0001211) | 1.55842047 |
| 140 | Long eyelashes (HP:0000527) | 1.55489992 |
| 141 | Cerebral inclusion bodies (HP:0100314) | 1.54835615 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.54090885 |
| 143 | Abnormal auditory evoked potentials (HP:0006958) | 1.53866397 |
| 144 | Tibial bowing (HP:0002982) | 1.53731997 |
| 145 | Pulmonic stenosis (HP:0001642) | 1.53144091 |
| 146 | Absent hand (HP:0004050) | 1.51775397 |
| 147 | Blepharitis (HP:0000498) | 1.49485837 |
| 148 | Cortical dysplasia (HP:0002539) | 1.49221995 |
| 149 | Loss of speech (HP:0002371) | 1.47538114 |
| 150 | Thoracolumbar scoliosis (HP:0002944) | 1.46591638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 3.66174911 |
| 2 | RIPK4 | 2.75487187 |
| 3 | YES1 | 2.46720143 |
| 4 | MAP3K14 | 2.45550168 |
| 5 | KDR | 2.23785579 |
| 6 | TGFBR1 | 2.22840255 |
| 7 | INSRR | 2.16300851 |
| 8 | PNCK | 2.08801804 |
| 9 | TRIB3 | 2.01715175 |
| 10 | TTN | 2.00425576 |
| 11 | TGFBR2 | 1.99956135 |
| 12 | ERN1 | 1.99625928 |
| 13 | TBK1 | 1.99582223 |
| 14 | MAP2K3 | 1.96405666 |
| 15 | LATS2 | 1.88573545 |
| 16 | CDK12 | 1.84341005 |
| 17 | PKN2 | 1.82731680 |
| 18 | IRAK4 | 1.82122350 |
| 19 | MAP3K3 | 1.77841874 |
| 20 | STK3 | 1.77541724 |
| 21 | RIPK1 | 1.74021829 |
| 22 | KIT | 1.73305255 |
| 23 | BMX | 1.69822912 |
| 24 | RPS6KA4 | 1.67846425 |
| 25 | CDK6 | 1.64661273 |
| 26 | SIK3 | 1.63944484 |
| 27 | TYK2 | 1.63323930 |
| 28 | PAK4 | 1.60759377 |
| 29 | ACVR1B | 1.60477322 |
| 30 | PDGFRA | 1.57306955 |
| 31 | MAP3K2 | 1.56782955 |
| 32 | MAP4K1 | 1.52788024 |
| 33 | PTK6 | 1.51061577 |
| 34 | STK10 | 1.49192134 |
| 35 | PIM1 | 1.47137401 |
| 36 | KSR1 | 1.44289398 |
| 37 | KSR2 | 1.43418649 |
| 38 | TYRO3 | 1.42148238 |
| 39 | PDGFRB | 1.41485436 |
| 40 | CSK | 1.34513629 |
| 41 | NEK9 | 1.34189789 |
| 42 | LMTK2 | 1.33959693 |
| 43 | DDR2 | 1.33046769 |
| 44 | PIM2 | 1.31571408 |
| 45 | ERBB3 | 1.29268118 |
| 46 | MATK | 1.27617366 |
| 47 | CAMK1G | 1.27293908 |
| 48 | NLK | 1.22745881 |
| 49 | BLK | 1.19359586 |
| 50 | LRRK2 | 1.18853247 |
| 51 | LATS1 | 1.17404727 |
| 52 | JAK3 | 1.16862839 |
| 53 | CHUK | 1.16458347 |
| 54 | MET | 1.13963450 |
| 55 | PBK | 1.11410010 |
| 56 | WNK1 | 1.10016195 |
| 57 | MARK3 | 1.08658120 |
| 58 | MST4 | 1.07967159 |
| 59 | DYRK3 | 1.07651840 |
| 60 | CDC42BPA | 1.07289180 |
| 61 | IRAK3 | 1.06672634 |
| 62 | FGFR3 | 0.96904770 |
| 63 | STK4 | 0.96207953 |
| 64 | STK38L | 0.94666829 |
| 65 | JAK1 | 0.94229944 |
| 66 | ABL2 | 0.93332125 |
| 67 | ZAP70 | 0.91862327 |
| 68 | IKBKB | 0.88625086 |
| 69 | BRD4 | 0.87888958 |
| 70 | EPHB2 | 0.86681885 |
| 71 | PTK2B | 0.86450000 |
| 72 | TEC | 0.85727334 |
| 73 | SGK3 | 0.84062669 |
| 74 | TRPM7 | 0.83385077 |
| 75 | EGFR | 0.82358151 |
| 76 | FGR | 0.82139942 |
| 77 | IKBKE | 0.82043930 |
| 78 | NEK2 | 0.80652115 |
| 79 | IRAK1 | 0.80599987 |
| 80 | TAOK3 | 0.80408829 |
| 81 | MAP3K5 | 0.78057398 |
| 82 | PAK2 | 0.77977228 |
| 83 | PRKG2 | 0.77026590 |
| 84 | BCR | 0.76402794 |
| 85 | EPHB1 | 0.75277769 |
| 86 | FER | 0.74466459 |
| 87 | HCK | 0.74338781 |
| 88 | SGK2 | 0.72012318 |
| 89 | MAP3K10 | 0.71903574 |
| 90 | FGFR1 | 0.71110081 |
| 91 | ALK | 0.70328918 |
| 92 | MAP3K6 | 0.69821669 |
| 93 | FES | 0.67786971 |
| 94 | EPHA2 | 0.67507768 |
| 95 | STK24 | 0.67312568 |
| 96 | FLT3 | 0.67158357 |
| 97 | MKNK1 | 0.66449477 |
| 98 | MOS | 0.66419911 |
| 99 | ERBB4 | 0.65115433 |
| 100 | CDK9 | 0.63961780 |
| 101 | CDK4 | 0.63870956 |
| 102 | MST1R | 0.63543064 |
| 103 | ABL1 | 0.63516979 |
| 104 | PTK2 | 0.63368983 |
| 105 | DMPK | 0.62336433 |
| 106 | BMPR2 | 0.61798156 |
| 107 | MAP3K8 | 0.61515322 |
| 108 | RET | 0.61208855 |
| 109 | CAMK1D | 0.59534235 |
| 110 | PRPF4B | 0.59496041 |
| 111 | JAK2 | 0.58054858 |
| 112 | IRAK2 | 0.56475970 |
| 113 | MAP3K11 | 0.54191684 |
| 114 | GRK7 | 0.52654807 |
| 115 | PIK3CG | 0.50937387 |
| 116 | BRSK2 | 0.50215931 |
| 117 | NUAK1 | 0.49956784 |
| 118 | STK38 | 0.49484513 |
| 119 | TAOK2 | 0.49311483 |
| 120 | MELK | 0.49064184 |
| 121 | CSF1R | 0.49051667 |
| 122 | MTOR | 0.48493708 |
| 123 | LCK | 0.48123359 |
| 124 | RPS6KA6 | 0.47815292 |
| 125 | GSK3A | 0.47544136 |
| 126 | EPHA3 | 0.47131146 |
| 127 | ERBB2 | 0.44932051 |
| 128 | TXK | 0.44281024 |
| 129 | TNIK | 0.43434760 |
| 130 | MAP3K13 | 0.42490937 |
| 131 | LYN | 0.41688330 |
| 132 | AKT2 | 0.41493788 |
| 133 | TAOK1 | 0.40910308 |
| 134 | FGFR4 | 0.39904858 |
| 135 | SIK1 | 0.39718418 |
| 136 | MAP3K1 | 0.39671887 |
| 137 | INSR | 0.38855474 |
| 138 | TAF1 | 0.37708402 |
| 139 | BTK | 0.37000146 |
| 140 | RAF1 | 0.36344085 |
| 141 | PDPK1 | 0.36094193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.68006784 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.08575268 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.03853945 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01266857 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00067566 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95139706 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.92232163 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86195245 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85574584 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.82707838 |
| 11 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.79694494 |
| 12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77624103 |
| 13 | Tuberculosis_Homo sapiens_hsa05152 | 1.70047467 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69023865 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62851070 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.60510631 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.59291060 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.58621658 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.57941380 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.55736655 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55391185 |
| 22 | Shigellosis_Homo sapiens_hsa05131 | 1.54224317 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.53787418 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.53693750 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50952810 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47346709 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.46636210 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.42936257 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.41835387 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40743066 |
| 31 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.40481545 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38376067 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.38276192 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36799612 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35333290 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34892301 |
| 37 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34811366 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34645388 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.34186738 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.32449538 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23755376 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18517980 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.17483621 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.16799873 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16209604 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15881310 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15437540 |
| 48 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.11414203 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10866076 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08904931 |
| 51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08835334 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07001032 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05517655 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05182557 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.02680946 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00695821 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99161404 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.97623754 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95494717 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95230085 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95137622 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.93876050 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93005937 |
| 64 | Prostate cancer_Homo sapiens_hsa05215 | 0.89621633 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88137745 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87873784 |
| 67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86616512 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.86528075 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86093108 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84509073 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84435804 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84234793 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83028967 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82435481 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81380782 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.81235988 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81122558 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80809281 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.79444533 |
| 80 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78882356 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78204636 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.77552832 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76611285 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75940170 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75720366 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.75338242 |
| 87 | Pathways in cancer_Homo sapiens_hsa05200 | 0.74600686 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71572144 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71357786 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70670395 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69558370 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69533347 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67922806 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.66993190 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66685256 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.66398884 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65916167 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65861238 |
| 99 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63525267 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.63326281 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.63181458 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63143217 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61705709 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61414128 |
| 105 | Glioma_Homo sapiens_hsa05214 | 0.61331690 |
| 106 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60551596 |
| 107 | Long-term depression_Homo sapiens_hsa04730 | 0.60309420 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59827660 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59092447 |
| 110 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.55685103 |
| 111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54702899 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53147280 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52659796 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52294991 |
| 115 | Cell cycle_Homo sapiens_hsa04110 | 0.52021097 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51959255 |
| 117 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48431991 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47208682 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47096960 |

